Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328313 · ClinicalTrials.gov registry record · NA
Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02328313 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 134 participants.
The verdict
NCT02328313, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
To determine if exercise will affect the increase in p16 expression that is associated with both chemotherapy administration and advancing age.
Interventions
- BEHAVIORAL Walk with Ease Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2014-10 |
| Est. Completion | 2019-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02328313
The ClinicalTrials.gov registry entry for NCT02328313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walk with Ease Program is the first listed.
NCT02328313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02328313 about?
NCT02328313 is a clinical study titled "Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older". To determine if exercise will affect the increase in p16 expression that is associated with both chemotherapy administration and advancing age.
What is the current status of trial NCT02328313?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2014-10. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT02328313?
The interventions under investigation include: Walk with Ease Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02328313?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.